The effect of initial polymer morphology on the degradation and drug release from polyglycolide.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 12013188.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polyglycolide is a degradable polyester which has been proposed for use as a matrix for controlled drug release. This paper assesses the effects of the initial morphology of the polymer on its behaviour during hydrolytic degradation. The initial morphology does not have a dramatic effect on the progress of degradation, the levels of crystallinity attained during the early stages of degradation being independent of the initial morphology. A sudden increase in both the mass loss and water uptake of the samples occurs after 10 days regardless of the initial morphology, and this is attributed to the formation of a porous surface layer, which occurs when the polymer matrix reaches a critical molecular weight. However, the initial morphology does affect the release profiles of a model drug, theophylline, from the matrices. Samples with a higher initial crystallinity release more drug at earlier stages of the degradation. This is probably due to a partitioning of drug molecules to the surfaces and an increase in the concentration of drug in the amorphous phase.
Medical subject headings
- Biocompatible Materials
- Drug Carriers
- Polyglycolic Acid